Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription Access

Vol 31, No 1 (2025)

Cover Page

Full Issue

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Original Research Articles

Legal risks in the work of a traumatologist associated with defects in the provision of emergency medical care

Egiazaryan K.A., Lyadova M.V., Ershov D.S., Badriev D.A.

Abstract

BACKGROUND: According to the literature, there is a steady increase in citizens' complaints about the quality of medical care.

AIM: The study aims to analyze the conclusions of forensic medical examinations of the most problematic groups of patients with acute injuries of the musculoskeletal system from the point of view of legal risk, to correlate adverse outcomes and common defects in medical care that are important in the legal assessment of the actions of a traumatologist, as well as to identify organizational measures to improve the quality of medical care.

METHODS: A sample analysis of 150 conclusions of the commission of forensic medical examinations was performed. All examinations were conducted in different expert institutions in Moscow and the Moscow region in the period from 2019–2023. A content analysis of regulatory legal documents regulating the activities in the provision of medical care to patients with an emergency injury has been performed. A correlation was made between the unfavorable outcome and the identified defects in the provision of medical care to patients with acute injuries. Due to the fact that these medical care defects are nominal, we have applied Pearson's χ2.

RESULTS: In the analysis of expert opinions, in most cases, defects in the provision of medical care were identified — 137 (91.3%), of which 47 (31.3%) conclusions contain 2 or more defects simultaneously. In 49 cases (32.7%), the expert assessment of the nature of the damage and the treatment plan was influenced by a defect in the management of medical records; in 38 cases (25.3%) — defects in treatment; in 27 cases (18.0%) — defects in diagnosis; in 19 cases (12.6%) — defects in the organization of medical care. Diagnostic defects related to missed fractures were detected in 18 (12.0%) cases. Most of the diagnostic defects were noted at the outpatient stage of medical care provision in a trauma center. Among the reasons for incorrect diagnosis, the following can be distinguished: inattentive examination of the victim, incorrect description of radiographs by a radiologist or a later description (for the next day or more), the inability to perform more high-tech and other research methods other than X-ray, for example, computed tomography or ultrasound.

CONCLUSION: In emergency traumatology, the probability of an adverse outcome is most affected by treatment defects (the relative risk was 1.21 with 25.3% of treatment defects — from 0.776 to 2.307). In the specialty "traumatology and orthopedics", there is a need to create scientifically sound, relevant to modern requirements of medical activity, clinical guidelines for patients with injuries of the musculoskeletal system, as well as to develop protocols for the provision of medical care to patients with polytrauma.

Medical Journal of the Russian Federation. 2025;31(1):7-17
pages 7-17 views

Reviews

Current perspective on the problem of autoimmune gastritis

Shcherbachenya N.A., Vasilenko K.V.

Abstract

Currently, there is an increase in the prevalence of autoimmune diseases. In particular, against the background of a decrease in the incidence of Helicobacter pylori associated gastritis, the number of patients with autoimmune gastritis increases. This is an autoimmune disease in which the destruction of the acid-producing gastric mucosa occurs due to the loss of parietal cells with their replacement by atrophic and metaplastic tissue, which leads to impaired absorption of iron, vitamin B12, deficiency states, anemia, neurological disorders and the development of malignant tumors. It is not fully known what triggers aggression. It is assumed that the autoimmune process can occur due to the interaction of genetic and environmental factors. In addition, the relationship between H. pylori and the development of autoimmune gastritis has not been fully studied.

Diagnosis of autoimmune gastritis is based on serological markers, but its leading method is esophagogastroduodenoscopy with biopsy. Several endoscopic signs allow one to suspect autoimmune gastritis: reverse atrophy; the presence of islets of preserved acid-producing mucosa; viscous mucus; protrusions in the body of the stomach, which are currently called "white spheres"; glomus formations, which are a proliferation of enterochromaffin-like cells. Atrophy of the mucous membrane of the body of the stomach is detected in biopsy material; three stages of inflammation of the mucous membrane of the body of the stomach can also be observed. Patients with autoimmune gastritis have an increased risk of developing malignant neoplasms, namely type 1 neuroendocrine tumors and adenocarcinoma. Therefore, regular monitoring is necessary for the early detection of these pathologies. However, the monitoring intervals have not been definitively determined. Most sources indicate the need for gastroscopy once every 1–3 years.

Medical Journal of the Russian Federation. 2025;31(1):18-29
pages 18-29 views

Modern aspects to the management of pregnant women with chronic hypertension

Chulkov V.S., Veber V.R., Gasanov M.Z., Chulkov V.S., Minina E.E., Nikolenko E.S.

Abstract

Women with chronic hypertension (CH) are at risk of various adverse fetal/neonatal outcomes, some of which can be mitigated by appropriate pregnancy management. The risk of complications in women with CH increases with hypertension severity and organ damage. With an increase in the relative risk of these complications, the absolute risk of serious damage to target organs (heart, kidneys, brain) remains low in the absence of preeclampsia or uncontrolled hypertension. Careful monitoring of blood pressure, including the use of home monitoring of the pregnant woman herself, allows minimizing the use of medications, especially in the first trimester, according to physiological changes in blood pressure in the second and third trimesters of pregnancy and the start of antihypertensive drugs ≥140/90 mmHg.

There is no doubt that antihypertensive therapy has benefits for women with CH. However, it should be remembered that the long-term goals for treating hypertension in adults fundamentally differ from those for treating hypertension in the short term. The general principle is to gradually reduce blood pressure to avoid a significant decrease in blood flow in the uteroplacental bloodstream. The choice of an antihypertensive drug depends on the safety of the drug, the degree of increase in blood pressure, the availability of drugs, the doctor's experience, as well as side effects and contraindications. The key to managing women with CH is pre-pregnancy counseling about pregnancy risks and possible interventions to minimize these risks.

This review systematizes national and international approaches for the management of pregnant women with CH using evidence-based medicine. Modern recommendations should become the basis for personalized management and treatment of pregnant women with CH.

Medical Journal of the Russian Federation. 2025;31(1):30-38
pages 30-38 views

The role of matrix metalloproteinase 9 as a biological marker in heart failure

Alieva A.M., Rahaev A.M., Sultangalieva A.B., Baykova I.E., Karakizova A.M., Totolyan G.G., Elmurzaeva J.A., Akkiev M.I., Khachukaeva L.A., Asanov A.O., Musukaev A.A., Nikitin I.G.

Abstract

Heart failure (HF) is an important medical, social and economic problem. The study of new biological markers deepens our understanding of the pathogenesis of this disease. In modern cardiology, there is a growing interest in matrix metalloproteinases (MMPs). These enzymes play an important role in tissue remodeling, angiogenesis, as well as in cell proliferation, migration and differentiation.

The purpose of this literature review is to analyze current experimental and clinical data on MMP-9 as a new diagnostic and prognostic marker in HF. This review presents an analysis of modern publications on a given topic. We conducted an analysis of literature sources covering all important materials as of 01.12.2024. Experimental studies have established that MMP-9 is a key participant in cardiac remodeling, since it is directly involved in the degradation of extracellular matrix proteins and the activation of profibrotic pathways, as well as cytokines and chemokines. Clinical trial data indicate the significant importance of MMP-9 for diagnosis and prognosis in patients with HF.

Medical Journal of the Russian Federation. 2025;31(1):39-50
pages 39-50 views

The effect of vitamins and micronutrients on the intestinal microbiota in norm and pathology

Nekrasova A.I., Kalashnikova I.G., Petryaykina E.S., Nekrasov A.S., Yudin V.S., Makarov V.V., Keskinov A.A., Yudin S.M.

Abstract

It is known that the intestinal microbiome plays an important role in many biological processes of the human body. However, all factors and mechanisms influencing changes in the composition of the intestinal microbiome are not fully understood. As the results of previous studies show, long-term food preferences play a significant role in modulating the composition of the intestinal microbiota. At the same time, all the mechanisms fully reflecting the peculiarities of the relationship of vitamins, trace elements, and the composition of the intestinal microbiota are not adequately characterized.

Vitamins and trace elements have a bidirectional effect on the intestinal microbiota. On the one hand, they influence the composition of the microbiota, its representation, number, and diversity. On the other hand, the microbiota is involved in the metabolism of trace elements, including the synthesis of certain vitamins.

In this review, we have tried to summarize the currently known information reflecting the relationship between the main microelements and the bacterial community of the gut. The review showed that some vitamins, with additional use, entering the colon modulate its microbiome, increase and maintain the bacterial diversity of the gut microbiota, which affects the amount of synthesized short-chain fatty acids. Several vitamins, such as vitamins A and D, can also affect intestinal immunity and its barrier functions.

Medical Journal of the Russian Federation. 2025;31(1):51-60
pages 51-60 views

Bariatric surgery as an important step towards kidney transplantation in patients with morbid obesity and chronic kidney disease

Voronets E.M., Smirnov A.V., Stankevich V.R., Abdulkerimov Z.A., Panchenkov D.N., Sharobaro V.I., Ivanov Y.V.

Abstract

An analysis of scientific studies devoted to the problem of bariatric surgery in patients with stages IIIb–V as chronic kidney disease (CKD) as the main step towardspossible kidney transplantation is presented. Obesity leads to CKD both directly, acting as an independent risk factor, and indirectly, by increasing the risk of diabetes, hypertension and atherosclerosis (i.e., a group of independent risk factors for CKD). CKD with an outcome of chronic renal failure is the second most common cause of mortality and disability in obese patients. In most kidney transplantation centers, a body mass index of more than 40 kg/m2 is a contraindication for to transplantation (refusal to be included on the waiting list); and a body mass index of more than 35 kg/m2 is a relative contraindication. In some cases, bariatric surgery is the only way to perform organ transplantation. Direct indications for bariatric surgery in patients with morbid obesity undergoing hemodialysis therapy have been identified. The established diet before/after bariatric surgery with the inclusion of protein isolate is not the cause of protein overload in patients with CKD. Bariatric surgery is considered a safe treatment option for obesity in potential kidney transplant candidates, given their continued need for immunosuppressive therapy.

Medical Journal of the Russian Federation. 2025;31(1):61-67
pages 61-67 views

Computer vision syndrome from the standpoint of principles of diagnostics and treatment of accommodative and sensory visual fatigue: literature review

Ovechkin I.G., Shavshina D.A.

Abstract

The review was performed using databases Russian Science Citation Index and PubMed, with the search keywords being "computer vision syndrome", "accommodation", "quality of life", "visual performance", "critical fusion and flicker frequency", "contrast sensitivity". The sources were selected in accordance with the criteria of prospective or retrospective studies. The data obtained indicate that the problem of diagnosis and treatment of accommodative and sensory visual fatigue in patients with computer vision syndrome is relevant in modern conditions of industrial activity due to the high frequency of distribution and possible negative impact on labor productivity. By now, the literature has formulated the basic principles of diagnostics and treatment of accommodative visual fatigue associated with the use of objective (accommodography) and subjective (quality of life) research methods, as well as the use of specific treatment methods (exposure to low-energy laser radiation, magnetophoresis, hardware optical-reflex training) taking into account a differentiated approach to the type of asthenopia. Much less developed is the problem of sensory visual fatigue, based on diagnostics using special research methods (critical frequency of fusion and flickering, contrast sensitivity at low spatial frequencies) and the implementation of therapeutic and restorative measures taking into account the syndrome-pathogenetic approach to the use of physical methods of treatment, one of which (in the long term) is ophthalmochromotherapy.

Medical Journal of the Russian Federation. 2025;31(1):68-75
pages 68-75 views

Case reports

Obstructive sleep apnea in patients with bradyarrhythmias

Yunyaeva M.V., Bulavina I.A., Baymukanov A.M., Weissman Y.D., Evmenenko A.A., Ilyich I.L., Termosesov S.A.

Abstract

BACKGROUND: Obstructive sleep apnea (OSA) is associated with various cardiovascular diseases, including arterial hypertension, chronic heart failure, and cardiac rhythm and conduction disorders. In some patients, preexisting bradycardia may not be directly related to OSA. Therefore, it is advisable to rule out OSA in patients referred for pacemaker implantation.

CLINICAL CASES DESCRIPTION: OSA is a common condition frequently associated with bradyarrhythmias. In some cases, treatment for such patients involves the implantation of a permanent endocardial pacemaker. Undiagnosed OSA may lead to an increased number of unnecessary pacemaker implantations, emphasizing the importance of timely diagnosis and treatment of this condition. This article presents clinical observations of seven patients with nocturnal bradyarrhythmias, which resolved following continuous positive airway pressure (CPAP) therapy.

The use of CPAP therapy contributed to the improvement of cardiovascular parameters, including the reduction in the number and duration of heart rhythm pauses. Clinically significant bradyarrhythmias were resolved in patients, allowing them to avoid surgical intervention. In the described cases, patients demonstrated a high apnea–hypopnea index (35.0–79.5 episodes per hour), a significant decrease in blood oxygen saturation (minimum up to 50%), and significant heart rhythm disturbances during the night. The initiation of CPAP therapy led to a reduction in the apnea–hypopnea index (1.9–23.1 episodes per hour), normalization of minimum oxygen saturation (80–93%), and the elimination of prolonged rhythm pauses.

CONCLUSION: The findings highlight the necessity of mandatory screening for OSA in patients with nocturnal bradyarrhythmias before planning pacemaker implantation. CPAP therapy effectively eliminates rhythm disturbances associated with sleep apnea and prevents unnecessary surgical procedures. This confirms the importance of a comprehensive approach to the diagnosis and treatment of this category of patients and the need for further large-scale studies to optimize their management tactics.

Medical Journal of the Russian Federation. 2025;31(1):76-84
pages 76-84 views

Drug-associated nephrotic syndrome in a child with Wilson's disease

Paunova S.S., Labutina N.V., Zubavina M.N., Shibilova M.M., Skvortsova T.A., Strokova T.V., Bagaeva M.E., Nikitin A.V., Do Egito C.K., Safina A.I., Daminova M.A., Khoreva M.V., Rusova M.A., Semenova N.А.

Abstract

BACKGROUND: Wilson's disease (WD) (synonyms: Wilson–Konovalov disease, hepatolenticular degeneration, hepatocerebral dystrophy) is a rare, severe, hereditary multisystem disorder that manifests itself primarily in liver, neurological, and psychiatric disorders due to excessive copper deposition in organs and tissues. The long latent course and polymorphism of clinical symptoms make diagnostics difficult. WD manifests itself in childhood, adolescence, and later in life. WD diagnostics is based on a combination of clinical symptoms, laboratory test data (determination of ceruloplasmin levels in the blood, copper excretion in the urine), and molecular genetic testing.

Complex treatment of WD primarily involves adherence to a copper-eliminating diet. A mandatory condition for the effectiveness of treatment of patients with WD is lifelong chelation therapy. The drug of choice in all age groups is penicillamine (a penicillin derivative), which has a significant number of side effects. Adverse reactions against the background of penicillamine therapy develop in about 30% of cases. These include changes in the nervous system (loss of taste, pyridoxine-deficiency polyneuritis), respiratory system (interstitial pneumonitis, diffuse fibrosing alveolitis, Goodpasture's syndrome), digestive system (decreased appetite, nausea, vomiting, diarrhea, aphthous stomatitis, glossitis, intrahepatic cholestasis, pancreatitis), kidneys (nephritis, nephrotic syndrome, hematuria).

CLINICAL CASE DESCRIPTION: The case history of a 6-year-old girl with WD is analyzed. The peculiarity of the clinical case presented by us is the latent course of the disease, which was suspected when cytolysis syndrome was detected in connection with an examination for episodic abdominal pain. Further examination showed a decrease in the concentration of ceruloplasmin, initially borderline values of copper excretion in urine, and questionable values in the penicillamine test. Molecular genetic testing was important for establishing the diagnosis, and confirming the diagnosis. Prescribed chelation therapy with penicillamine led to the normalization of cytolysis syndrome parameters, but caused serious adverse events in the form of nephrotic syndrome, which required replacing penicillamine with trientine and prescribing glucocorticoids. Against the background of treatment correction, stable clinical and laboratory remission of nephrotic syndrome was achieved with satisfactory renal and liver function parameters and no manifestations of cytolysis.

CONCLUSION: A moderate increase in biochemical markers of cytolysis, cholestasis, and bilirubin concentration, refractory to standard treatment, requires in-depth examination, including molecular genetics, to exclude WD. If side effects of penicillamine derivatives are detected, immediate correction of pathogenetic therapy with replacement of the chelating drug is necessary.

Medical Journal of the Russian Federation. 2025;31(1):85-93
pages 85-93 views


Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».